Share ACR on Air
Share to email
Share to Facebook
Share to X
By American College of Rheumatology
4.9
5757 ratings
The podcast currently has 103 episodes available.
We are proud to present the highly anticipated “ACR 2024 Lupus Nephritis Guideline” with First Author and frequent guest, Dr. Lisa R. Sammaritano. A decade in the making, we reflect on the significant advancements in available therapies, the guideline’s holistic approach to managing Lupus Nephritis (LN) across all age groups, and include insights on combination therapies, minimizing glucocorticoid use and how to manage the full spectrum of patients with Lupus Nephritis.
As we continue to highlight sessions from Convergence 2024, we came upon this talk we think you should not miss: Emerging Threats in Rheumatology: Chronic Chikungunya Arthritis and Syphilis Mimicking Rheumatic Diseases. Session presenters, Dr. Jose Kennedy Amaral Pereira and Dr. Daniela DiMarco help us explore the world of emerging threats in rheumatology: specifically, Chikungunya Arthritis and Syphilis. These two experts share insights with us to help diagnose and manage those with these devastating infections and highlight for us how important it is for rheumatologists to remain on high alert for these infections, which can be easily mistaken for more common rheumatic disorders!
Can Artificial Intelligence (AI) ever replace the clinician or the researcher? Today, we explore the promises and pitfalls of this transformative technology and its implications for rheumatology. From assistance in diagnosis and patient care to its role in research and academic writing, our two guests Dr. Amanda Nelson and Dr. Bella Mehta will walk us through how our field is utilizing AI today and where it may lead in the near future. Most of all, they’ll explain how we can harness its power...without getting burned.
When should we choose rituximab over cyclophosphamide? What role can avacopan play as an adjunct therapy? When is plasma exchange a viable option? How can we effectively navigate steroid tapering? These are just a few of the critical questions we’ll explore with our next guest, Dr. Tanaz Kermani, founder and director of the Vasculitis Program at UCLA, a dedicated clinician and active researcher. Join us as we delve into these topics and address the challenges of diagnosing and managing patients with vasculitis.
Dr. Sara McCoy, rheumatologist and Sjögren’s specialist, a “Sjögrensologist”, joins us this week for an in-depth look at Sjögren’s Disease. We address how the systemic nature of this disease can affect everything from the lungs to the kidneys, why traditional treatments may not always work, why a patient’s antibody profile may hold the key to their disease severity, the use of new biomarkers, the role of advanced diagnostics and ground-breaking developments in the use of stromal cells in treatment and so much more!
Our annual preview episode for Convergence is here, and we have AMPC (Annual Meeting Planning Committee) Chair, Dr. Greg Gardner as our guest! Dr. Gardner walks us through this meeting’s focus and strategies, which are designed to make ACR24 even more engaging, delivering cutting edge science, more networking opportunities, improved educational experiences and new initiatives to better the lives of our patients. We’ll discuss how Convergence has adapted to a post-pandemic era, get a glimpse of “must attend” sessions, and even hear about the new networking lounge and some insider tips to make the most of your stay in Washington D.C.
What are Inborn Errors of Immunity (IEI) and what should be done if you suspect them? Dr. Bharat Kumar, clinical rheumatologist and allergy immunologist, joins us to lend his insights on what they are, how to identify them in our patients, the challenges in diagnosing them, and how they manifest in a clinical setting. Dr. Kumar also explains how IEI’s are caused, their overlap with rheumatic diseases and recent advancements in treatments.
This week, the ACR is kicking off Rheumatic Disease Awareness Month (RDAM), and we’ve got Dr. Shah who introduces the concept of self-management, which can help improve the control of rheumatic disease beyond medication and empower our patients to take active roles in the management of them. Dr. Shah also spends time highlighting resources available for self-management and addresses how the ACR is advocating for improved healthcare polices and patient support and what you can do to take part in that process!
As physicians, ethical challenges are a certainty for us. Some can be spotted easily and avoided, but what do we do when the choices are not obvious, and a path isn’t clear? We must trust our tools to fashion a way forward. Today, we discuss some of today’s most relevant moral dilemmas with the Chair of the ACR Ethics Committee, Dr. Kelly Weselman. We’ll touch on the balance between patient autonomy and medical recommendations, navigating the complexities of access to care and treatment costs, and managing conflicts of interest. At the bottom of the show, we explore the evolving ethical landscape that is influenced by technological advancements and the increasing availability of information.
Master rheumatologist, Dr. Philip J. Mease, joins us for a deep dive into psoriatic arthritis (PsA). Dr. Mease explains how to diagnose PsA in patients, the latest treatments, his insights on evaluating joint pain, the role of enthesitis and axial involvement and how to differentiate between inflammatory and non-inflammatory causes of joint pain in those with PsA. This was an enlightening discussion with a master physician that we know you’ll enjoy!
The podcast currently has 103 episodes available.
456 Listeners
113 Listeners
263 Listeners
3,293 Listeners
109 Listeners
117 Listeners
165 Listeners
501 Listeners
7 Listeners
4 Listeners
161 Listeners
1 Listeners
0 Listeners
4 Listeners
16 Listeners